Does the media prefer CELC or PRVA?

In the previous week, Celcuity and Celcuity both had 4 articles in the media. Privia Health Group's average media sentiment score of 0.74 beat Celcuity's score of 0.47 indicating that Privia Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Privia Health Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer PRVA or PACS?

In the previous week, Privia Health Group had 2 more articles in the media than PACS Group. MarketBeat recorded 4 mentions for Privia Health Group and 2 mentions for PACS Group. Privia Health Group's average media sentiment score of 0.74 beat PACS Group's score of 0.00 indicating that Privia Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to HIMS or PRVA?

In the previous week, Hims & Hers Health had 18 more articles in the media than Privia Health Group. MarketBeat recorded 22 mentions for Hims & Hers Health and 4 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.74 beat Hims & Hers Health's score of 0.57 indicating that Privia Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 9 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Positive Privia Health Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SHC or PRVA?

In the previous week, Privia Health Group had 1 more articles in the media than Sotera Health. MarketBeat recorded 4 mentions for Privia Health Group and 3 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.10 beat Privia Health Group's score of 0.74 indicating that Sotera Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Privia Health Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Privia Health Group (PRVA) Competitors

$21.51 0.00 (0.00%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$21.55 +0.04 (+0.17%)

As of 05/29/2026 07:00 PM Eastern

Compare

PRVA vs. BTSG, CELC, PACS, HIMS, and SHC

Should you buy Privia Health Group stock or one of its competitors? MarketBeat compares Privia Health Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Privia Health Group include BrightSpring Health Services (BTSG), Celcuity (CELC), PACS Group (PACS), Hims & Hers Health (HIMS), and Sotera Health (SHC). These companies are all part of the "healthcare" industry.

How does Privia Health Group compare to BrightSpring Health Services?

Privia Health Group (NASDAQ:PRVA) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

BrightSpring Health Services has a net margin of 2.27% compared to Privia Health Group's net margin of 0.97%. BrightSpring Health Services' return on equity of 14.63% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	0.97%	2.81%	1.61%
BrightSpring Health Services	2.27%	14.63%	4.41%

Privia Health Group has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.87, indicating that its share price is 87% more volatile than the broader market.

BrightSpring Health Services has higher revenue and earnings than Privia Health Group. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.28	$22.92M	$0.16	134.44
BrightSpring Health Services	$12.91B	0.93	$190.67M	$1.41	43.74

94.5% of Privia Health Group shares are held by institutional investors. 5.7% of Privia Health Group shares are held by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Privia Health Group presently has a consensus target price of $31.15, suggesting a potential upside of 44.83%. BrightSpring Health Services has a consensus target price of $57.00, suggesting a potential downside of 7.59%. Given Privia Health Group's higher probable upside, equities research analysts plainly believe Privia Health Group is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	3.12

In the previous week, BrightSpring Health Services had 5 more articles in the media than Privia Health Group. MarketBeat recorded 9 mentions for BrightSpring Health Services and 4 mentions for Privia Health Group. BrightSpring Health Services' average media sentiment score of 1.18 beat Privia Health Group's score of 0.74 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BrightSpring Health Services	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

BrightSpring Health Services beats Privia Health Group on 12 of the 17 factors compared between the two stocks.

How does Privia Health Group compare to Celcuity?

Celcuity (NASDAQ:CELC) and Privia Health Group (NASDAQ:PRVA) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

Privia Health Group has a net margin of 0.97% compared to Celcuity's net margin of 0.00%. Privia Health Group's return on equity of 2.81% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Privia Health Group	0.97%	2.81%	1.61%

Privia Health Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Privia Health Group	$2.12B	1.28	$22.92M	$0.16	134.44

63.3% of Celcuity shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 13.3% of Celcuity shares are owned by insiders. Comparatively, 5.7% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Celcuity and Celcuity both had 4 articles in the media. Privia Health Group's average media sentiment score of 0.74 beat Celcuity's score of 0.47 indicating that Privia Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Privia Health Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Celcuity has a beta of 0.1, indicating that its stock price is 90% less volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.9, indicating that its stock price is 10% less volatile than the broader market.

Celcuity presently has a consensus target price of $150.27, suggesting a potential upside of 13.09%. Privia Health Group has a consensus target price of $31.15, suggesting a potential upside of 44.83%. Given Privia Health Group's higher possible upside, analysts plainly believe Privia Health Group is more favorable than Celcuity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Summary

Privia Health Group beats Celcuity on 11 of the 13 factors compared between the two stocks.

How does Privia Health Group compare to PACS Group?

Privia Health Group (NASDAQ:PRVA) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings, media sentiment and dividends.

PACS Group has higher revenue and earnings than Privia Health Group. PACS Group is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.28	$22.92M	$0.16	134.44
PACS Group	$5.29B	1.10	$191.54M	$1.56	23.48

PACS Group has a net margin of 4.49% compared to Privia Health Group's net margin of 0.97%. PACS Group's return on equity of 26.47% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	0.97%	2.81%	1.61%
PACS Group	4.49%	26.47%	4.36%

In the previous week, Privia Health Group had 2 more articles in the media than PACS Group. MarketBeat recorded 4 mentions for Privia Health Group and 2 mentions for PACS Group. Privia Health Group's average media sentiment score of 0.74 beat PACS Group's score of 0.00 indicating that Privia Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Privia Health Group presently has a consensus price target of $31.15, indicating a potential upside of 44.83%. PACS Group has a consensus price target of $48.00, indicating a potential upside of 31.07%. Given Privia Health Group's stronger consensus rating and higher possible upside, analysts clearly believe Privia Health Group is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

94.5% of Privia Health Group shares are held by institutional investors. 5.7% of Privia Health Group shares are held by company insiders. Comparatively, 70.1% of PACS Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Privia Health Group beats PACS Group on 8 of the 15 factors compared between the two stocks.

How does Privia Health Group compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Privia Health Group (NASDAQ:PRVA) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 5.7% of Privia Health Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Hims & Hers Health has higher revenue and earnings than Privia Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.58	$128.37M	-$0.09	N/A
Privia Health Group	$2.12B	1.28	$22.92M	$0.16	134.44

In the previous week, Hims & Hers Health had 18 more articles in the media than Privia Health Group. MarketBeat recorded 22 mentions for Hims & Hers Health and 4 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.74 beat Hims & Hers Health's score of 0.57 indicating that Privia Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	9 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Positive
Privia Health Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hims & Hers Health has a beta of 2.37, meaning that its stock price is 137% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market.

Privia Health Group has a net margin of 0.97% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Privia Health Group	0.97%	2.81%	1.61%

Hims & Hers Health currently has a consensus price target of $28.70, indicating a potential upside of 9.88%. Privia Health Group has a consensus price target of $31.15, indicating a potential upside of 44.83%. Given Privia Health Group's stronger consensus rating and higher possible upside, analysts clearly believe Privia Health Group is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Summary

Privia Health Group beats Hims & Hers Health on 9 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Privia Health Group (NASDAQ:PRVA) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, valuation and media sentiment.

Sotera Health has higher earnings, but lower revenue than Privia Health Group. Sotera Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	3.83	$77.94M	$0.41	38.15
Privia Health Group	$2.12B	1.28	$22.92M	$0.16	134.44

Sotera Health has a beta of 1.79, suggesting that its stock price is 79% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.9, suggesting that its stock price is 10% less volatile than the broader market.

In the previous week, Privia Health Group had 1 more articles in the media than Sotera Health. MarketBeat recorded 4 mentions for Privia Health Group and 3 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.10 beat Privia Health Group's score of 0.74 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Privia Health Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

91.0% of Sotera Health shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 15.4% of Sotera Health shares are held by company insiders. Comparatively, 5.7% of Privia Health Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Sotera Health presently has a consensus target price of $20.33, suggesting a potential upside of 30.01%. Privia Health Group has a consensus target price of $31.15, suggesting a potential upside of 44.83%. Given Privia Health Group's stronger consensus rating and higher possible upside, analysts clearly believe Privia Health Group is more favorable than Sotera Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Sotera Health has a net margin of 9.91% compared to Privia Health Group's net margin of 0.97%. Sotera Health's return on equity of 39.73% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Privia Health Group	0.97%	2.81%	1.61%

Summary

Sotera Health beats Privia Health Group on 9 of the 16 factors compared between the two stocks.

Get Privia Health Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRVA vs. The Competition

Export

Metric	Privia Health Group	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.71B	$1.54B	$6.57B	$12.58B
Dividend Yield	N/A	N/A	2.68%	5.31%
P/E Ratio	134.45	78.38	21.59	26.25
Price / Sales	1.28	6.77	561.77	114.93
Price / Cash	80.60	22.84	27.44	37.60
Price / Book	3.35	4.79	10.04	6.86
Net Income	$22.92M	-$54.76M	$3.56B	$337.26M
7 Day Performance	-5.62%	0.66%	2.82%	3.58%
1 Month Performance	N/A	N/A	N/A	-0.79%
1 Year Performance	-5.91%	-1.83%	37.62%	39.67%

Privia Health Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRVA Privia Health Group	4.1741 of 5 stars	$21.51 flat	$31.15 +44.8%	-5.9%	$2.71B	$2.12B	134.45	1,226	Analyst Forecast
BTSG BrightSpring Health Services	4.3057 of 5 stars	$56.90 +1.3%	$56.29 -1.1%	+158.7%	$11.01B	$12.91B	40.28	23,500
CELC Celcuity	2.3957 of 5 stars	$133.71 +1.2%	$149.30 +11.7%	+1,145.4%	$6.54B	N/A	N/A	40	Analyst Forecast
PACS PACS Group	3.8604 of 5 stars	$36.26 -1.5%	$48.00 +32.4%	+268.8%	$5.72B	$5.29B	23.18	47,455	Analyst Upgrade
HIMS Hims & Hers Health	3.0978 of 5 stars	$22.66 +1.6%	$29.50 +30.2%	-54.0%	$5.14B	$2.35B	N/A	2,442	Analyst Forecast Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PRVA) was last updated on 6/1/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Privia Health Group (PRVA) Competitors

PRVA vs. BTSG, CELC, PACS, HIMS, and SHC

How does Privia Health Group compare to BrightSpring Health Services?

Summary

How does Privia Health Group compare to Celcuity?

Summary

How does Privia Health Group compare to PACS Group?

Summary

How does Privia Health Group compare to Hims & Hers Health?

Summary

How does Privia Health Group compare to Sotera Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRVA vs. The Competition

Privia Health Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Privia Health Group (PRVA) Competitors

PRVA vs. BTSG, CELC, PACS, HIMS, and SHC

How does Privia Health Group compare to BrightSpring Health Services?

Is PRVA or BTSG more profitable?

Which has more volatility and risk, PRVA or BTSG?

Which has stronger valuation & earnings, PRVA or BTSG?

Do insiders and institutionals hold more shares of PRVA or BTSG?

Do analysts rate PRVA or BTSG?

Does the media prefer PRVA or BTSG?

Summary

How does Privia Health Group compare to Celcuity?

Is CELC or PRVA more profitable?

Which has stronger valuation and earnings, CELC or PRVA?

Do insiders & institutionals hold more shares of CELC or PRVA?

Does the media prefer CELC or PRVA?

Which has more volatility and risk, CELC or PRVA?

Do analysts prefer CELC or PRVA?

Summary

How does Privia Health Group compare to PACS Group?

Which has higher valuation and earnings, PRVA or PACS?

Is PRVA or PACS more profitable?

Does the media prefer PRVA or PACS?

Do analysts recommend PRVA or PACS?

Do institutionals and insiders hold more shares of PRVA or PACS?

Summary

How does Privia Health Group compare to Hims & Hers Health?

Do insiders & institutionals have more ownership in HIMS or PRVA?

Which has better earnings & valuation, HIMS or PRVA?

Does the media refer more to HIMS or PRVA?

Which has more volatility & risk, HIMS or PRVA?

Is HIMS or PRVA more profitable?

Do analysts prefer HIMS or PRVA?

Summary

How does Privia Health Group compare to Sotera Health?

Which has preferable earnings & valuation, SHC or PRVA?

Which has more risk & volatility, SHC or PRVA?

Does the media prefer SHC or PRVA?

Do insiders and institutionals hold more shares of SHC or PRVA?

Do analysts rate SHC or PRVA?

Is SHC or PRVA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRVA vs. The Competition

Privia Health Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools